Clinical trial
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
NCT04089059
Study timeline
Study start (actual)2020-01-10Date precision: day
Registry last updated2026-07-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failure NYHA Class IIIunresolved
Interventions
Sponsors & collaborators
Endotronix, Inc.lead sponsor
Mapped research locations
HoustonTexas, United States3BostonMassachusetts, United States3New YorkNew York, United States2ChicagoIllinois, United States2PhiladelphiaPennsylvania, United States2BaltimoreMaryland, United States2San FranciscoCalifornia, United States2MinneapolisMinnesota, United States2MiamiFlorida, United States1San AntonioTexas, United States1NashvilleTennessee, United States1SeattleWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04089059 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.